Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.

The post Chlorine Dioxide, Raw Camel Milk: The FDA No Longer Warns Against These and Other Ineffective Autism Treatments appeared first on ProPublica.

Pfizer faces multi-year headwinds from loss of exclusivity and COVID franchise decline, but management highlights transformative M&A and pipeline optionality. Learn more on PFE stock here.

A few hours after White House border czar Tom Homan announced the end of the immigration crackdown in Minneapolis, a steady stream of mourners gathered on the city’s south side.

The FT reported today the growing evidence that Christine Lagarde will step down early from the European Central Bank ...

ImmunityBio commands a premium valuation on the promise of Anktiva, a chemo-free immunotherapy platform showing early efficacy and manageable safety. Learn more about IBRX stock here.

But while Bolsonaro’s efforts resembled what Donald Trump has done in his second term in the United States, the response from ...

What Brazil got right that America got wrong.

Booster vaccines reduced the risk of COVID‑19-related hospitalization and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England. The research, led by the ...

After initially rejecting Moderna’s application for review, the FDA will now consider the company’s mRNA flu shot ...

The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the company's application to market the new kind of influenza vaccine.